Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA vaccines: precision tools for activating effective immunity against cancer
Jason Rice, Christian H. Ottensmeier, Freda K. Stevenson
Nature reviews. Cancer (2008) Vol. 8, Iss. 2, pp. 108-120
Closed Access | Times Cited: 413

Showing 1-25 of 413 citing articles:

Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay, Elizabeth P. Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S185-S198
Open Access | Times Cited: 1408
DNA vaccines: ready for prime time?
Michele A. Kutzler, David B. Weiner
Nature Reviews Genetics (2008) Vol. 9, Iss. 10, pp. 776-788
Open Access | Times Cited: 1028
Personalized vaccines for cancer immunotherapy
Uǧur Şahin, Özlem Türeci
Science (2018) Vol. 359, Iss. 6382, pp. 1355-1360
Open Access | Times Cited: 918
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Cornelis J.M. Melief, Sjoerd H. van der Burg
Nature reviews. Cancer (2008) Vol. 8, Iss. 5, pp. 351-360
Closed Access | Times Cited: 560
Therapeutic cancer vaccines: past, present, and future.
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, et al.
Europe PMC (PubMed Central) (2013) Vol. 119, pp. 421-75
Open Access | Times Cited: 559
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 468
Classification of current anticancer immunotherapies
Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, et al.
Oncotarget (2014) Vol. 5, Iss. 24, pp. 12472-12508
Open Access | Times Cited: 440
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai, David B. Weiner
Current Opinion in Immunology (2011) Vol. 23, Iss. 3, pp. 421-429
Open Access | Times Cited: 396
Prostate cancer as a model for tumour immunotherapy
Charles G. Drake
Nature reviews. Immunology (2010) Vol. 10, Iss. 8, pp. 580-593
Open Access | Times Cited: 346
Polymer multilayer tattooing for enhanced DNA vaccination
Peter C. DeMuth, Younjin Min, Bonnie Huang, et al.
Nature Materials (2013) Vol. 12, Iss. 4, pp. 367-376
Open Access | Times Cited: 264
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Yuchen Fan, James J. Moon
Vaccines (2015) Vol. 3, Iss. 3, pp. 662-685
Open Access | Times Cited: 255
Nanomaterials for cancer immunotherapy
Wantong Song, Sara Musetti, Leaf Huang
Biomaterials (2017) Vol. 148, pp. 16-30
Open Access | Times Cited: 252
DNA vaccine for cancer immunotherapy
Benjamin Yang, Jessica Jeang, Andrew Yang, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3153-3164
Open Access | Times Cited: 246
RNA-Based Vaccines in Cancer Immunotherapy
Megan McNamara, Smita K. Nair, Eda K. Holl
Journal of Immunology Research (2015) Vol. 2015, pp. 1-9
Open Access | Times Cited: 195
Engineering patient-specific cancer immunotherapies
Lindsay Scheetz, Kyong Soo Park, Qiao Li, et al.
Nature Biomedical Engineering (2019) Vol. 3, Iss. 10, pp. 768-782
Open Access | Times Cited: 178
Polymeric Materials for Gene Delivery and DNA Vaccination
David N. Nguyen, Jordan J. Green, Juliana M. Chan, et al.
Advanced Materials (2008) Vol. 21, Iss. 8, pp. 847-867
Open Access | Times Cited: 265
DNA Vaccines: Developing New Strategies against Cancer
Daniela Piergili Fioretti, Sandra Iurescia, Vito Michele Fazio, et al.
Journal of Biomedicine and Biotechnology (2010) Vol. 2010, pp. 1-16
Open Access | Times Cited: 199
Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions
Mahmoud Elsabahy, Adil J. Nazarali, Marianna Földvári
Current Drug Delivery (2011) Vol. 8, Iss. 3, pp. 235-244
Closed Access | Times Cited: 195
In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
Sandhya Vasan, Arlene Hurley, Sarah J. Schlesinger, et al.
PLoS ONE (2011) Vol. 6, Iss. 5, pp. e19252-e19252
Open Access | Times Cited: 179
DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
Lindsey Low, Ann Mander, Katy J. McCann, et al.
Human Gene Therapy (2009) Vol. 20, Iss. 11, pp. 1269-1278
Closed Access | Times Cited: 174
Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
Willy Bogers, Herman Oostermeijer, Petra Mooij, et al.
The Journal of Infectious Diseases (2014) Vol. 211, Iss. 6, pp. 947-955
Open Access | Times Cited: 165
Drawing lithography for microneedles: A review of fundamentals and biomedical applications
Kwang Lee, Hyungil Jung
Biomaterials (2012) Vol. 33, Iss. 30, pp. 7309-7326
Closed Access | Times Cited: 154
Immunotherapy for Head and Neck Squamous Cell Carcinoma
Jessica Moskovitz, Jennifer Moy, Robert L. Ferris
Current Oncology Reports (2018) Vol. 20, Iss. 2
Open Access | Times Cited: 148
Recent trends in vaccine delivery systems: A review
P K Lakshmi, Shyamala Bhaskaran, CH Saroja
International Journal of Pharmaceutical Investigation (2011) Vol. 1, Iss. 2, pp. 64-64
Open Access | Times Cited: 145
Antigen-specific vaccines for cancer treatment
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3332-3346
Open Access | Times Cited: 145
Page 1 - Next Page

Scroll to top